155 related articles for article (PubMed ID: 8527093)
1. Changing prevalence of hepatitis B virus and hepatitis D virus infection among injecting drug users in Hong Kong indicating a change in high-risk behaviour.
Lim WL; Lo JY; Lee SH
AIDS; 1995 Sep; 9(9):1110-2. PubMed ID: 8527093
[No Abstract] [Full Text] [Related]
2. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
Kemp R; Miller J; Lungley S; Baker M
N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
[TBL] [Abstract][Full Text] [Related]
3. Sexual behaviour, drug use and hepatitis B infection in Chandigarh students.
Kaur U; Sahni SP; Bambery P; Kumar B; Chauhan A; Chawla YK; Dilawari JB
Natl Med J India; 1996; 9(4):156-9. PubMed ID: 8772330
[TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece.
Hadziyannis SJ; Dourakis SP; Papaioannou C; Alexopoulou A; Hadziyannis ES; Gioustozi A
Prog Clin Biol Res; 1993; 382():259-66. PubMed ID: 8502690
[No Abstract] [Full Text] [Related]
5. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
Boutayeb H; Aamoum A; Benchemsi N
East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
[TBL] [Abstract][Full Text] [Related]
6. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
[TBL] [Abstract][Full Text] [Related]
8. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
[TBL] [Abstract][Full Text] [Related]
12. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
Vallejo F; Toro C; de la Fuente L; Brugal MT; Soriano V; Silva TC; Bravo MJ; Ballesta R; Barrio G;
Eur Addict Res; 2008; 14(3):116-24. PubMed ID: 18552487
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus and viral hepatitis seroepidemiology in New York City intravenous drug abusers (IVDAs).
Brown LS; Kreek MJ; Trepo C; Chu A; Banks SE; Valdes M; Ajuluchukwu D; Phillips R; Primm BJ
NIDA Res Monogr; 1989; 95():443-4. PubMed ID: 2641023
[No Abstract] [Full Text] [Related]
16. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
17. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
[TBL] [Abstract][Full Text] [Related]
18. Targeting groups at high risk of hepatitis B.
Pendleton E; Sanger S
Community Nurse; 1996 Apr; 2(3):54-5. PubMed ID: 9445705
[No Abstract] [Full Text] [Related]
19. [Hepatitis B and C in intravenous drug abusers in Switzerland].
Steffen T; Gutzwiller F
Praxis (Bern 1994); 1999 Nov; 88(47):1937-44. PubMed ID: 10605327
[TBL] [Abstract][Full Text] [Related]
20. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
